DV
Dividend Vision

AVBP — ArriVent BioPharma, Inc.

ArriVent BioPharma, Inc. (AVBP)

Total return is 63.9% over the past 2.6 years, 0.0 points ahead of SPY at 63.9%. Its deepest 1-year drawdown was 24.2%.

AVBP is a healthcare equity fund that tracks a single stock in the biopharmaceutical sector. The fund does not currently distribute dividends to shareholders and therefore generates no yield. This fund appeals primarily to investors seeking targeted exposure to a specific healthcare company rather than those pursuing regular income distributions.

AVBP key facts

Asset type
Stock
Asset class
Equity
Inception date
01/25/2024
Distribution frequency
None
Last close
$29.51
Market cap
$1,455,071,104
Average volume
439000.0
Beta
1.366
Payout ratio
0.0
Forward P/E
0.0
EPS
$-3.55